Name : HLA-B Antibody
Supplier : NJS POLY
Price :406
SKU : GEN5306108598
| Category | Antibody |
| Concentration | pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form | Antigen affinity purified |
| Conjugation | Unconjugated |
| Clone | Polyclonal antibody |
| Recognised antigen | HLA-B |
| Host animal | Goat (Capra aegagrus hircus) |
| Clonality | Polyclonal (goat origin) |
| Species reactivity | Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications | ELISA (peptide), WB |
| Recommended dilutions | 1-0, 3ug/ml, ELISA (peptide) LOD: 1:64000, Western blot: 0 |
| Notes | Optimal dilution of the HLA-B antibody should be determined by the researcher |
| Intented use | This HLA-B antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID # | 3106 |
| Purity | Antigen affinity |
| Description | B alpha chain, Additional name(s) for this target protein: HLA class I histocompatibility antigen |
| Immunogen | Amino acids DRNTQIYKAQAQT were used as the immunogen for this HLA-B antibody |
| Storage | Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the HLA-B antibody at -20 deg |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target | HLA-B |
| Short name | HLA-B Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | B (Antibody to), class I, major histocompatibility complex |
| Alternative technique | antibodies |
| Alternative to gene target | AS and HLAB and SPDA1, B, Cell surfaces, HLA-B and IDBG-299578 and ENSG00000234745 and 3106, TAP-dependent and biological process this GO :0002480 and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent and biological process this GO :0002667 and regulation of T cell anergy and biological process this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006955 and immune response and biological process this GO :0009986 and cell surface and cellular component this GO :0012507 and ER to this GO lgi transport vesicle membrane and cellular component this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0016032 and viral process and biological process this GO :0019221 and cytokine-mediated signaling pathway and biological process this GO :0019882 and antigen processing and presentation and biological process this GO :0030670 and pha this GO cytic vesicle membrane and cellular component this GO :0031901 and early endosome membrane and cellular component this GO :0032655 and regulation of interleukin-12 production and biological process this GO :0032675 and regulation of interleukin-6 production and biological process this GO :0042270 and protection from natural killer cell mediated cytotoxicity and biological process this GO :0042590 and antigen processing and presentation of exogenous peptide antigen via MHC class I and biological process this GO :0042605 and peptide antigen binding and molecular function this GO :0042612 and MHC class I protein complex and cellular component this GO :0045087 and innate immune response and biological process this GO :0050776 and regulation of immune response and biological process this GO :0060333 and interferon-gamma-mediated signaling pathway and biological process this GO :0060337 and type I interferon signaling pathway and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0071556 and integral component of lumenal side of endoplasmic reticulum membrane and cellular component this GO :2001198 and regulation of dendritic cell differentiation and biological process, class I, peptide antigen binding, this GO :0000139 and this GO lgi membrane and cellular component this GO :0001916 and positive regulation of T cell mediated cytotoxicity and biological process this GO :0002474 and antigen processing and presentation of peptide antigen via MHC class I and biological process this GO :0002479 and antigen processing and presentation of exogenous peptide antigen via MHC class I, this GO :0005102: receptor binding, this GO :0005102: receptor binding and also this GO :0005515: protein binding and also this GO :0042605: peptide antigen binding, this GO :0005515: protein binding, this GO :0042605: peptide antigen binding, major histocompatibility complex |
| Identity | 4932 |
| Gene | HLA-B |
| Long gene name | B , class I, major histocompatibility complex |
| Synonyms gene | AS |
| Synonyms gene name | ankylosing spondylitis |
| Locus | 6p21, 33 |
| Discovery year | 2001-06-22 |
| GenBank acession | M15470 |
| Entrez gene record | 3106 |
| Pubmed identfication | 3459708 |
| RefSeq identity | NM_005514 |
| Classification | C1-set domain containing Histocompatibility complex |
| Havana BLAST/BLAT | OTTHUMG00000031153 |
| Locus Specific Databases | IMGT/HLA Database |